Jinling Pharmaceutical Company Limited announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,818.437 million compared to CNY 1,939.974 million a year ago. Operating income was CNY 124.506 million compared to CNY 342.237 million a year ago. Net income was CNY 77.601 million compared to CNY 236.375 million a year ago. Basic earnings per share from continuing operations was CNY 0.154 compared to CNY 0.469 a year ago.